Abstract
Rhazya Stricta (R. stricta) has been employed as a natural remedy for several diseases for centuries. Numerous studies revealed that R. stricta extracts contain alkaloids, tannins, and flavonoids that possess antimicrobial, anticancer, antihypertensive, and antioxidant activities. In this study, we examined the effects of organic extracts from different parts of R. stricta plant on human pluripotent stem cells (hiPSCs)-derived neural stem cells (NSCs) for medical purposes. NSCs were incubated with different concentrations of organic extracts from the leaves, stem, and fruits, and we assessed the growth and viability of the cells by using MTS assay and the chemical composition of the potential plant extract by using gas chromatography-mass spectrometry (GC/MS). Our results revealed that the methanolic extract from the stem increased NSCs growth significantly, particularly at a concentration of 25 μg/ml. GC/MS analysis was utilized to identify the potential compounds of the methanolic extract. In conclusion, our results demonstrated for the first time that methanolic stem extract of R. stricta contains compounds that can positively impact NSCs growth. These compounds can be further investigated to determine the potential bioactive compounds that can be used for research and medical purposes.
Funder
National Center for Biotechnology (NCB), Life Science and Environment Research Institute (LSERI), KACST
Publisher
Public Library of Science (PLoS)
Reference46 articles.
1. Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System;L. Ottoboni;Frontiers in Cell and Developmental Biology,2017
2. Stem cell transplantation for Huntington’s diseases;K.-A. Choi;Methods,2018
3. Human Neural Stem Cell Transplantation Rescues Cognitive Defects in APP/PS1 Model of Alzheimer’s Disease by Enhancing Neuronal Connectivity and Metabolic Activity;X. Li;Front Aging Neurosci,2016
4. Ethical Implications in the Use of Embryonic and Adult Neural Stem Cells;R. Ramos-Zúñiga;Stem Cells International,2012
5. Brain Region-Dependent Rejection of Neural Precursor Cell Transplants;N. Fainstein;Front Mol Neurosci,2018